Former OmicScouts

Momentum Biotechnologies EU (former OmicScouts GmbH) founded in 2014, is a proteomics company focused on supporting drug and biomarker discovery through unique expertise and innovative technologies. By providing and developing system-wide assays to monitor protein activity and function in a physiological context, OmicScouts enables the identification of small molecule drug targets, target engagement markers, molecular mechanisms of action, and drug response biomarkers. OmicScouts supports a wide variety of drug and biomarker discovery projects with end-to-end solutions tailored to project-specific needs, and the team has a strong track record of successful collaborations with top pharmaceutical and biotechnology companies. In 2025, OmicScouts was acquired by Momentum, a Biotechnology company based close to Boston, Massachusetts. expanding to the US market. It now operates as OmicScouts, a Momentum Biotechnologies Company. For more information, please visit www.omicscouts.com and www.momentum.bio.